2014
DOI: 10.1210/er.2013-1067
|View full text |Cite
|
Sign up to set email alerts
|

Isolated Growth Hormone Deficiency (GHD) in Childhood and Adolescence: Recent Advances

Abstract: The diagnosis of GH deficiency (GHD) in childhood is a multistep process involving clinical history, examination with detailed auxology, biochemical testing, and pituitary imaging, with an increasing contribution from genetics in patients with congenital GHD. Our increasing understanding of the factors involved in the development of somatotropes and the dynamic function of the somatotrope network may explain, at least in part, the development and progression of childhood GHD in different age groups. With respe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
80
0
7

Year Published

2016
2016
2021
2021

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 126 publications
(88 citation statements)
references
References 495 publications
(519 reference statements)
1
80
0
7
Order By: Relevance
“…In our 4-year follow-up cohort seven of 22 patients with hypothalamic-pituitary genetic defects progressed to MPHD (32%), predominantly those with PROP1 mutations, but also two patients with GH1 mutation. Development of MPHD in patients with GH1 mutation was not entirely unexpected as patients with IGHD and autosomal dominant heterozygous GH1 mutations have been reported to develop additional pituitary hormone deficiencies (20). Patients who developed MPHD during GH therapy were shorter at baseline and had more severe GHD than those who continued to have IGHD, reflecting the high prevalence of patients with history of intracranial tumour and known genetic defects of pituitary development in the MPHD group.…”
Section: Discussionmentioning
confidence: 96%
“…In our 4-year follow-up cohort seven of 22 patients with hypothalamic-pituitary genetic defects progressed to MPHD (32%), predominantly those with PROP1 mutations, but also two patients with GH1 mutation. Development of MPHD in patients with GH1 mutation was not entirely unexpected as patients with IGHD and autosomal dominant heterozygous GH1 mutations have been reported to develop additional pituitary hormone deficiencies (20). Patients who developed MPHD during GH therapy were shorter at baseline and had more severe GHD than those who continued to have IGHD, reflecting the high prevalence of patients with history of intracranial tumour and known genetic defects of pituitary development in the MPHD group.…”
Section: Discussionmentioning
confidence: 96%
“…(8,9) . Deficiência Isolada do Hormônio do Crescimento -(DIGH): a deficiência isolada do hormônio do crescimento é a deficiência hipofisária mais comum, com uma incidência relatada de 1 a cada 4000-10000 nascidos vivos, e pode ter origem congênita ou adquirida (10) .…”
Section: Introductionunclassified
“…Embora teoricamente possível, ate o momento não foram relatadas mutações no GHRH (10,11) . Raramente a DIGH pode resultar de mutações nos genes HESX1, GHSR, OTX2, GLI2, SOX3 e BTK (os dois últimos de herança ligada ao X) alguns dos quais também implicados nos casos de DHHM (10,12,13) .…”
Section: Introductionunclassified
See 2 more Smart Citations